Erythropoietin improves functional and histological recovery of traumatized skeletal muscle tissue

Journal of Orthopaedic Research

Volumn 26, Issue 12, 2008, Pages 1618-1626

  Rotter, Robert ^a   Menshykova, Marija ^a   Winkler, Tobias ^b   Matziolis, Georg ^b   Stratos, Ioannis ^a   Schoen, Matthias ^a   Bittorf, Thomas ^a   Mittlmeier, Thomas ^a   Vollmar, Brigitte ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Apoptosis; Contraction force; Inflammation; Microcirculation; Regeneration

Indexed keywords

ERYTHROPOIETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CRUSH TRAUMA; DRUG ACTIVITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LEYDIG CELL; MALE; MICROCIRCULATION; MUSCLE CONTRACTION; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE;

ANIMALS; APOPTOSIS; CELL LINE; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; MALE; MICROCIRCULATION; MUSCLE CONTRACTION; MUSCLE STRENGTH; MUSCLE, SKELETAL; RATS; RATS, WISTAR; RECEPTORS, ERYTHROPOIETIN; RECOVERY OF FUNCTION; REGENERATION; TIME FACTORS; WOUND HEALING;

EID: 56749098219     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20692     Document Type: Article

References (41)

1. Mac Auley DC. 2001. Ice therapy: how good is the evidence? Int J Sports Med 22:379-384.
2. Almekinders LC. 1999. Anti-inflammatory treatment of muscular injuries in sport. An update of recent studies. Sports Med 28:383-388.
3. Jarvinen TA, Jarvinen TL, Kaariainen M, et al. 2005. Muscle injuries: biology and treatment. Am J Sports Med 33:745-764.
4. Huard J, Li Y, Fu FH. 2002. Muscle injuries and repair: current trends in research. J. Bone Joint Surg Am 84:822-832.
5. Charge SB, Rudnicki MA. 2004. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84:209-238.
6. Ghezzi P, Brines M. 2004. Erythropoietin as an antiapoptotic, tissue-protective cytokine. Cell Death Differ 11:S37-S44.
7. Jelkmann W, Wagner K. 2004. Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Ann Hematol 83:673-686.
8. Jelkmann W. 2004. Molecular biology of erythropoietin. Intern Med 43:649-659.
9. Philpott NJ, Turner AJ, Scopes J, et al. 1996. The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood 87:2244-2251.
10. Matziolis G, Winkler T, Schaser K, et al. 2006. Autologous bone marrow-derived cells enhance muscle strength following skeletal muscle crush injury in rats. Tissue Eng 12:361-367.
11. Ferreira R, Neuparth MJ, Ascensao A, et al. 2006. Skeletal muscle atrophy increases cell proliferation in mice gastrocnemius during the first week of hindlimb suspension. Eur J Appl Physiol 97:340-346.
12. Tyml K, Budreau CH. 1991. A new preparation of the rat extensor digitorum longus muscle for intravital investigation of the microcirculation. Int J Microcirc Clin Exp 10:335-343.
13. Schaser KD, Vollmar B, Menger MD, et al. 1999. In vivo analysis of microcirculation following closed soft-tissue injury. J. Orthop Res 17:678-685.
14. Mittlmeier T, Vollmar B, Menger MD, et al. 2003. Small volume hypertonic hydroxyethyl starch reduces acute microvascular dysfunction after closed soft-tissue trauma. J. Bone Joint Surg Br 85:126-132.
15. Zhang L, Bail H, Mittlmeier T, et al. 2003. Immediate microcirculatory derangements in skeletal muscle and periosteum after closed tibial fracture. J. Trauma 54:979-985.
16. Gierer P, Mittlmeier T, Bordel R, et al. 2005. Selective cyclooxygenase-2 inhibition reverses microcirculatory and inflammatory sequelae of closed soft-tissue trauma in an animal model. J. Bone Joint Surg Am 87:153-160.
17. Gradl G, Gaida S, Gierer P, et al. 2004. In vivo evidence for apoptosis, but not inflammation in the hindlimb muscle of neuropathic rats. Pain 112:121-130.
18. Stratos I, Rotter R, Eipel C, et al. 2007. Granulocyte-colony stimulating factor enhances muscle proliferation and strength following skeletal muscle injury in rats. J. Appl Physiol 103:1857-1863.
19. Smith HK, Maxwell L, Rodgers CD, et al. 2001. Exercise-enhanced satellite cell proliferation and new myonuclear accretion in rat skeletal muscle. J. Appl Physiol 90:1407-1414.
20. Kay DG, Yue P, Hanna Z, et al. 2002. Cardiac disease in transgenic mice expressing human immunodeficiency virus-1 nef in cells of the immune system. Am J Pathol 161:321-335.
21. Calvillo L, Latini R, Kajstura J, et al. 2003. Recombinant human erythropoietin protects the myocardium from ischemia - reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA 100:4802-4806.
22. Belayev L, Khoutorova L, Zhao W, et al. 2005. Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats. Stroke 36:1071-1076.
23. Johnson DW, Pat B, Vesey DA, et al. 2006. Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int 69:1806-1813.
24. Agnello D, Bigini P, Villa P, et al. 2002. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res 952:128-134.
25. Villa P, Bigini P, Mennini T, et al. 2003. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp Med 198:971-975.
26. Vesey DA, Cheung C, Pat B, et al. 2004. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 19:348-355.
27. Parsa CJ, Matsumoto A, Kim J, et al. 2003. A novel protective effect of erythropoietin in the infarcted heart. J. Clin Invest 112:999-1007.
28. Menger MD, Sack FU, Barker JH, et al. 1988. Quantitative analysis of microcirculatory disorders after prolonged ischemia in skeletal muscle. Therapeutic effects of prophylactic isovolemic hemodilution. Res Exp Med 188:151-165.
29. Tidball JG. 2005. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 288:R345-R353.
30. Menger MD, Vollmar B. 1994. In vivo analysis of microvascular reperfusion injury in striated muscle and skin. Microsurgery 15:383-389.
31. Menger MD, Pelikan S, Steiner D, et al. 1992. Microvascular ischemia-reperfusion injury in striated muscle: significance of "reflow paradox". Am J Physiol 263:H1901-H1906.
32. Chong ZZ, Kang JQ, Maiese K. 2002. Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases. Circulation 106:2973-2979.
33. Martinez-Estrada OM, Rodriguez-Millan E, Gonzalez-De Vicente E, et al. 2003. Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J Neurosci 18:2538-2544.
34. Menger MD, Rucker M, Vollmar B. 1997. Capillary dysfunction in striated muscle ischemia/reperfusion: on the mechanisms of capillary "no- reflow". Shock 8:2-7.
35. Wald MR, Borda ES, Sterin-Borda L. 1996. Mitogenic effect of erythropoietin on neonatal rat cardiomyocytes: signal transduction pathways. J. Cell Physiol 167:461-468.
36. Anderson JE. 2006. The satellite cell as a companion in skeletal muscle plasticity: currency, conveyance, clue, connector and colander. J. Exp Biol 209:2276-2292.
37. Ehrhardt J, Morgan J. 2005. Regenerative capacity of skeletal muscle. Curr Opin Neurol 18:548-553.
38. Ferrari G, Cusella-De Angelis G, Coletta M, et al. 1998. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279:1528-1530.
39. Pennisi E. 1998. Bone marrow cells may provide muscle power. Science 279:1456.
40. Ogilvie M, Yu X, Nicolas-Metral V, et al. 2000. Erythropoietin stimulates proliferation and interferes with differentiation of myoblasts. J. Biol Chem 275:39754-39761.
41. Parsa CJ, Kim J, Riel RU, et al. 2004. Cardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblasts. J. Biol Chem 279:20655-20662.